Theratechnologies THTX Stock
Theratechnologies Price Chart
Theratechnologies THTX Financial and Trading Overview
| Theratechnologies stock price | 1.64 USD |
| Previous Close | 0.94 USD |
| Open | 0.96 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 0.92 - 0.97 USD |
| 52 Week Range | 0.7 - 2.77 USD |
| Volume | 21.87K USD |
| Avg. Volume | 54.3K USD |
| Market Cap | 94.13M USD |
| Beta (5Y Monthly) | 1.525252 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.17 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.38 USD |
THTX Valuation Measures
| Enterprise Value | 127.83M USD |
| Trailing P/E | N/A |
| Forward P/E | -7.986667 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.1563314 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.57 |
| Enterprise Value/EBITDA | -6.256 |
Trading Information
Theratechnologies Stock Price History
| Beta (5Y Monthly) | 1.525252 |
| 52-Week Change | -60.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.77 USD |
| 52 Week Low | 0.7 USD |
| 50-Day Moving Average | 0.93 USD |
| 200-Day Moving Average | 1.32 USD |
THTX Share Statistics
| Avg. Volume (3 month) | 54.3K USD |
| Avg. Daily Volume (10-Days) | 79.67K USD |
| Shares Outstanding | 96.81M |
| Float | 86.92M |
| Short Ratio | 0.99 |
| % Held by Insiders | 0.83% |
| % Held by Institutions | 28.73% |
| Shares Short | 46.76K |
| Short % of Float | 0.050% |
| Short % of Shares Outstanding | 0.050% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | November 30, 2023 |
Profitability
| Profit Margin | -59.75% |
| Operating Margin (ttm) | -38.37% |
| Gross Margin | 70.94% |
| EBITDA Margin | -25.10% |
Management Effectiveness
| Return on Assets (ttm) | -20.78% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 81.41M USD |
| Revenue Per Share (ttm) | 0.85 USD |
| Quarterly Revenue Growth (yoy) | 7.29% |
| Gross Profit (ttm) | 56.22M USD |
| EBITDA | -20434000 USD |
| Net Income Avi to Common (ttm) | -48648000 USD |
| Diluted EPS (ttm) | -0.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.16M USD |
| Total Cash Per Share (mrq) | 0.3 USD |
| Total Debt (mrq) | 65.99M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.835 |
| Book Value Per Share (mrq) | -0.334 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12341000 USD |
| Levered Free Cash Flow (ttm) | 10.36M USD |
Profile of Theratechnologies
| Country | United States |
| State | QC |
| City | Montreal |
| Address | 2015 Peel Street |
| ZIP | H3A 1T8 |
| Phone | 514 336 7800 |
| Website | https://www.theratech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 144 |
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Q&A For Theratechnologies Stock
What is a current THTX stock price?
Theratechnologies THTX stock price today per share is 1.64 USD.
How to purchase Theratechnologies stock?
You can buy THTX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Theratechnologies?
The stock symbol or ticker of Theratechnologies is THTX.
Which industry does the Theratechnologies company belong to?
The Theratechnologies industry is Biotechnology.
How many shares does Theratechnologies have in circulation?
The max supply of Theratechnologies shares is 45.98M.
What is Theratechnologies Price to Earnings Ratio (PE Ratio)?
Theratechnologies PE Ratio is now.
What was Theratechnologies earnings per share over the trailing 12 months (TTM)?
Theratechnologies EPS is -0.17 USD over the trailing 12 months.
Which sector does the Theratechnologies company belong to?
The Theratechnologies sector is Healthcare.
Theratechnologies THTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
| NASDAQ Capital Market Composite RCMP | 91.92 USD — |
-0.27
|
— — | 86.91 USD — | 95.14 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}